Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review.

Huber, D; Seitz, S; Kast, K; Emons, G; Ortmann, O

Huber, D; Seitz, S; Kast, K; Emons, G; Ortmann, O.

Afiliação

Huber D; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.
Seitz S; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.
Kast K; Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
Emons G; Department of Gynecology and Obstetrics, Georg August University Göttingen, University Medicine, Göttingen, Germany.
Ortmann O; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany. olaf.ortmann@klinik.uni-regensburg.de.

Arch Gynecol Obstet ; 301(4): 875-884, 2020 04.

Article em En | MEDLINE | ID: mdl-32140806

Assuntos

Neoplasias da Mama/induzido quimicamente; Anticoncepcionais Orais/efeitos adversos; Neoplasias Ovarianas/induzido quimicamente; Adulto; Neoplasias da Mama/genética; Estudos de Casos e Controles; Feminino; Humanos; Mutação; Neoplasias Ovarianas/genética; Estudos Prospectivos; Estudos Retrospectivos

Palavras-chave

BRCA1; BRCA2; Breast cancer; Oral contraception; Ovarian cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Anticoncepcionais Orais Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google